Jpmorgan Chase & CO Neuro Sense Therapeutics Ltd. Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
Shares
1 transactions
Others Institutions Holding NRSN
# of Institutions
10Shares Held
246KCall Options Held
0Put Options Held
0-
Cantor Fitzgerald, L. P. New York, NY79.5KShares$92,2100.01% of portfolio
-
Xtx Topco LTD London, X046KShares$53,3550.0% of portfolio
-
Meitav Dash Investments LTD40KShares$46,4000.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il34.3KShares$39,7640.0% of portfolio
-
Stratos Wealth Partners, Ltd.20KShares$23,2000.0% of portfolio
About NeuroSense Therapeutics Ltd.
- Ticker NRSN
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,674,000
- Market Cap $13.5M